Literature DB >> 26359870

Adverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance: a single-center experience.

Marco Dollinger1, Lukas Philipp Beyer, Michael Haimerl, Christoph Niessen, Ernst Michael Jung, Florian Zeman, Christian Stroszczynski, Philipp Wiggermann.   

Abstract

PURPOSE: We aimed to describe the frequency of adverse events after computed tomography (CT) fluoroscopy-guided irreversible electroporation (IRE) of malignant hepatic tumors and their risk factors.
METHODS: We retrospectively analyzed 85 IRE ablation procedures of 114 malignant liver tumors (52 primary and 62 secondary) not suitable for resection or thermal ablation in 56 patients (42 men and 14 women; median age, 61 years) with regard to mortality and treatment-related complications. Complications were evaluated according to the standardized grading system of the Society of Interventional Radiology. Factors influencing the occurrence of major and minor complications were investigated.
RESULTS: No IRE-related death occurred. Major complications occurred in 7.1% of IRE procedures (6/85), while minor complications occurred in 18.8% (16/85). The most frequent major complication was postablative abscess (4.7%, 4/85) which affected patients with bilioenteric anastomosis significantly more often than patients without this condition (43% vs. 1.3%, P = 0.010). Bilioenteric anastomosis was additionally identified as a risk factor for major complications in general (P = 0.002). Minor complications mainly consisted of hemorrhage and portal vein branch thrombosis.
CONCLUSION: The current study suggests that CT fluoroscopy-guided IRE ablation of malignant liver tumors may be a relatively low-risk procedure. However, patients with bilioenteric anastomosis seem to have an increased risk of postablative abscess formation.

Entities:  

Mesh:

Year:  2015        PMID: 26359870      PMCID: PMC4622394          DOI: 10.5152/dir.2015.14442

Source DB:  PubMed          Journal:  Diagn Interv Radiol        ISSN: 1305-3825            Impact factor:   2.630


  34 in total

1.  Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the "heat sink" effect.

Authors:  David S K Lu; Steven S Raman; Darko J Vodopich; Michael Wang; James Sayre; Charles Lassman
Journal:  AJR Am J Roentgenol       Date:  2002-01       Impact factor: 3.959

2.  Cancer cells ablation with irreversible electroporation.

Authors:  Liron Miller; Jonathan Leor; Boris Rubinsky
Journal:  Technol Cancer Res Treat       Date:  2005-12

Review 3.  Cell injury by electric forces.

Authors:  Raphael C Lee
Journal:  Ann N Y Acad Sci       Date:  2005-12       Impact factor: 5.691

4.  Image-guided tumor ablation: standardization of terminology and reporting criteria.

Authors:  S Nahum Goldberg; Clement J Grassi; John F Cardella; J William Charboneau; Gerald D Dodd; Damian E Dupuy; Debra A Gervais; Alice R Gillams; Robert A Kane; Fred T Lee; Tito Livraghi; John McGahan; David A Phillips; Hyunchul Rhim; Stuart G Silverman; Luigi Solbiati; Thomas J Vogl; Bradford J Wood; Suresh Vedantham; David Sacks
Journal:  J Vasc Interv Radiol       Date:  2009-07       Impact factor: 3.464

5.  Bilio-enteric anastomosis as a risk factor for postembolic hepatic abscesses.

Authors:  K Okajima; S Kohno; M Tamaki; M Hosono; M Kawamoto; Y Nishiyama; M Sugano; T Miyaoka
Journal:  Cardiovasc Intervent Radiol       Date:  1989 May-Jun       Impact factor: 2.740

6.  Ablation of perivascular hepatic malignant tumors with irreversible electroporation.

Authors:  T Peter Kingham; Ami M Karkar; Michael I D'Angelica; Peter J Allen; Ronald P Dematteo; George I Getrajdman; Constantinos T Sofocleous; Stephen B Solomon; William R Jarnagin; Yuman Fong
Journal:  J Am Coll Surg       Date:  2012-06-16       Impact factor: 6.113

7.  Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications.

Authors:  T F Wood; D M Rose; M Chung; D P Allegra; L J Foshag; A J Bilchik
Journal:  Ann Surg Oncol       Date:  2000-09       Impact factor: 5.344

8.  Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation.

Authors:  Edward W Lee; Christine Chen; Veronica E Prieto; Sarah M Dry; Christopher T Loh; Stephen T Kee
Journal:  Radiology       Date:  2010-05       Impact factor: 11.105

9.  Radio-frequency tissue ablation: effect of pharmacologic modulation of blood flow on coagulation diameter.

Authors:  S N Goldberg; P F Hahn; E F Halpern; R M Fogle; G S Gazelle
Journal:  Radiology       Date:  1998-12       Impact factor: 11.105

10.  Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study.

Authors:  Tito Livraghi; Luigi Solbiati; M Franca Meloni; G Scott Gazelle; Elkan F Halpern; S Nahum Goldberg
Journal:  Radiology       Date:  2003-02       Impact factor: 11.105

View more
  12 in total

Review 1.  New Approaches in Locoregional Therapies for Hepatocellular Carcinoma.

Authors:  Riccardo Memeo; Vito de Blasi; Zineb Cherkaoui; Ammar Dehlawi; Nicola De' Angelis; Tullio Piardi; Daniele Sommacale; Jacques Marescaux; Didier Mutter; Patrick Pessaux
Journal:  J Gastrointest Cancer       Date:  2016-09

2.  Ultrasound-guided percutaneous irreversible electroporation of hepatic and abdominal tumors not eligible for surgery or thermal ablation: a western report on safety and efficacy.

Authors:  A Giorgio; F Amendola; A Calvanese; E Ingenito; B Santoro; P Gatti; E Ciracì; P Matteucci; V Giorgio
Journal:  J Ultrasound       Date:  2019-03-06

3.  Irreversible electroporation of malignant liver tumors: Effect on laboratory values.

Authors:  Mohammed Alnaggar; Ammar M Qaid; Jibing Chen; Lizhi Niu; Kecheng Xu
Journal:  Oncol Lett       Date:  2018-07-02       Impact factor: 2.967

Review 4.  Combination of natural killer cell-based immunotherapy and irreversible electroporation for the treatment of hepatocellular carcinoma.

Authors:  Aydin Eresen; Jia Yang; Alessandro Scotti; Kejia Cai; Vahid Yaghmai; Zhuoli Zhang
Journal:  Ann Transl Med       Date:  2021-07

Review 5.  Irreversible electroporation of hepatocellular carcinoma: patient selection and perspectives.

Authors:  Asha Zimmerman; David Grand; Kevin P Charpentier
Journal:  J Hepatocell Carcinoma       Date:  2017-03-13

6.  The Safety and Efficacy of Irreversible Electroporation for Large Hepatocellular Carcinoma.

Authors:  Jianying Zeng; Guifeng Liu; Zhong-Hai Li; Yi Yang; Gang Fang; Rong-Rong Li; Ke-Cheng Xu; Lizhi Niu
Journal:  Technol Cancer Res Treat       Date:  2016-11-11

7.  Similar complication rates for irreversible electroporation and thermal ablation in patients with hepatocellular tumors.

Authors:  Niklas Verloh; Isabel Jensch; Lukas Lürken; Michael Haimerl; Marco Dollinger; Philipp Renner; Philipp Wiggermann; Jens Martin Werner; Florian Zeman; Christian Stroszczynski; Lukas Philipp Beyer
Journal:  Radiol Oncol       Date:  2019-03-03       Impact factor: 2.991

8.  Intratumoral STING Agonist Injection Combined with Irreversible Electroporation Delays Tumor Growth in a Model of Hepatocarcinoma.

Authors:  Aritz Lasarte-Cia; Teresa Lozano; David Cano; Celia Martín-Otal; Flor Navarro; Marta Gorraiz; Noelia Casares; Isabel Vivas; Juan José Lasarte
Journal:  Biomed Res Int       Date:  2021-01-27       Impact factor: 3.411

9.  Integrating interventional oncology in the treatment of liver tumors.

Authors:  D Putzer; P Schullian; E Braunwarth; M Fodor; F Primavesi; B Cardini; T Resch; R Oberhuber; M Maglione; C Margreiter; S Schneeberger; S Stättner; D Öfner-Velano; W Jaschke; R J Bale
Journal:  Eur Surg       Date:  2018-04-13       Impact factor: 0.953

Review 10.  Irreversible Electroporation For Liver Tumors: A Review Of Literature.

Authors:  Asim Tameez Ud Din; Ahsan Tameez-Ud-Din; Farooq Mohyud Din Chaudhary; Noman A Chaudhary; Khaleeq H Siddiqui
Journal:  Cureus       Date:  2019-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.